CACNA1C and congenital bilateral aplasia of vas deferens from CFTR mutation: Thus, targeting NFAT-dependent transcription with inhibitors such as cyclosporine or tacrolimus may offer opportunities to prevent or delay progression of CAVD beyond the suggested efficacy of CaV1.2 Ca2+ channel antagonists such as verapamil that was effective in our mouse model.